- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03703583
Infant Feeding Practice and Gut Comfort Study
Infant Feeding Practice and Gut Comfort: a Multi-country, Cross-sectional Observational Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a cross-sectional single time point study. Infants and caregivers who come to a clinic for a routine health visit who wish to participate in the study by signing the consent form and meet all inclusion criteria/exclusion criteria will be enrolled.
At the visit, a research staff member will assist the parents to complete (i) Feeding Practice and Gut Comfort Questionnaire and (ii) Infant Gastrointestinal Symptom (IGSQ)-13 items. Additionally, infant's anthropometrics (weight, length, head circumference) will be recorded. These anthropometrics will be measured by the researcher as part of the routine visit.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Alexandria, Egypt
- Alexandria University
-
Assiut, Egypt
- Assuit University
-
Cairo, Egypt
- Cairo University
-
Cairo, Egypt
- Ain Shams University
-
Tanta, Egypt
- Tanta University
-
Zagazig, Egypt
- Zagazig University
-
-
-
-
-
Chennai, India
- Apollo Children's Hospital
-
Kolkata, India
- ICH Hospital
-
Thāne, India
- Dr Praveen Gokhales Childrens Clinic and Vaccination Centre
-
-
-
-
-
Yogyakarta, Indonesia
- Faculty of Medicine Universitas Gadjah Mada
-
-
-
-
-
Kuala Lumpur, Malaysia, 50603
- University of Malaya
-
-
-
-
-
Islamabad, Pakistan
- PIMS
-
Karachi, Pakistan
- National Institute of Child Health
-
Lahore, Pakistan
- The Children Hospital & Institute of Child Health
-
Rawalpindi, Pakistan
- BBH
-
-
-
-
-
Quezon City, Philippines, 1112
- St.Luke'S College of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy full term (37-42 weeks of gestation) singleton infant.
- Postnatal age ≥ 6 weeks and ≤ 4 months
- Parent as primary Caregiver and ≥ 18 years old
- Exclusively/predominantly breastfeeding or exclusively/predominantly formula feeding of the same type/brand, for at least the past 2 weeks.
- Evidence of personally signed and dated informed consent document by the infant's parent(s).
Exclusion Criteria:
- Chronic illness necessitating medical follow up
- Acute ongoing or recent (last 2 weeks) illness necessitating medical follow up
- Any known case of food allergy (e.g milk)
- Caregivers who are not likely to comply with the study procedures
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Exclusively/predominantly Breastfeeding group
|
There is no intervention in this observational study.
|
Exclusively/predominantly Formula feeding group
|
There is no intervention in this observational study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
An index score of overall GI symptom burden
Time Frame: single time point between 6 weeks to 4 months
|
Measured by Validated, standardized infant Gastrointestinal Symptom Questionnaire (IGSQ-13)
|
single time point between 6 weeks to 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
GI Symptoms
Time Frame: single time point between 6 weeks to 4 months
|
measured by IGSQ-13 questionnaires (An overall index score is calculated from 13 questions in the questionnaire as a measure of total GI symptom burden.
The values for the IGSQ index score can range from 13 (low GI burden) to 65 (high GI burden))
|
single time point between 6 weeks to 4 months
|
Stool characteristics
Time Frame: one day recall before study visit
|
measured by Feeding Practice and Gut Comfort Questionnaire (frequency and consistency)
|
one day recall before study visit
|
Physician-reported and parent-reported Colic
Time Frame: Single time point between 6 weeks to 4 months
|
measured by Feeding Practice and Gut Comfort Questionnaire based on ROME IV diagnosis criteria.
Effect of feeding group on the prevalence of colic will be assessed by logistic regression.
|
Single time point between 6 weeks to 4 months
|
Collaborators and Investigators
Investigators
- Study Chair: Yvan Vandenplas, Universitair Ziekenhuis Brussel
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 17.12.INF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Infants
-
Société des Produits Nestlé (SPN)Active, not recruitingHealthy InfantsFrance, Belgium, Germany, Spain
-
Société des Produits Nestlé (SPN)Completed
-
CHU de ReimsCompleted
-
Danone Asia Pacific Holdings Pte, Ltd.CompletedHealthy InfantsThailand, Indonesia
-
Junlebao Dairy Group Co., Ltd.Merieux NutriSciences (China)Recruiting
-
NestléCompleted
-
Danone NutriciaNutricia Early Life Nutrition (Shanghai) Co., LtdCompletedHealthy InfantsChina
-
Monell Chemical Senses CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Seattle Children's HospitalCompleted
-
Société des Produits Nestlé (SPN)Not yet recruitingHealthy Infants
Clinical Trials on There is no intervention in this observational study.
-
University of HaifaRambam Health Care CampusCompletedParkinson DiseaseIsrael
-
Queens College, The City University of New YorkNational Cancer Institute (NCI)UnknownMortality
-
KU LeuvenCompletedCongenital Heart DiseaseBotswana, United States, Korea, Republic of, Belgium, Sweden, France, Switzerland, Denmark, Pakistan, Norway, Taiwan, Malta, Brazil, Bulgaria, India, Austria, Argentina, Australia, Cameroon, Canada, Chile, Colombia, Ethiopia, Greece, Italy and more
-
Maimónides Biomedical Research Institute of CórdobaCompletedInvasive FusariosisSpain
-
Amsterdam UMC, location VUmcRecruitingCoronary Artery DiseaseNetherlands
-
ProgenaBiomeRecruitingGastrointestinal Microbiome | Gut MicrobiomeUnited States
-
Unity Health TorontoSunnybrook Health Sciences Centre; University of British Columbia; Alberta Health... and other collaboratorsCompleted
-
ProgenaBiomeRecruitingCoronaviridae Infections | COVID-19 | COVID 19 | COVID | Corona Virus Infection | Coronavirus | Gastrointestinal Microbiome | Gut Microbiome | Coronavirus-19 | Coronavirus 19United States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOcular Hypertension | Glaucoma, Open-AngleCanada
-
University of GeorgiaCompletedHuman PapillomavirusUnited States